XML 49 R36.htm IDEA: XBRL DOCUMENT v3.25.3
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Nov. 01, 2025
STOCK-BASED COMPENSATION  
Schedule of options outstanding, vested or expected to vest, and exercisable

WEIGHTED-

WEIGHTED-

AGGREGATE

AVERAGE

AVERAGE

INTRINSIC

EXERCISE

REMAINING TERM

VALUE

SHARES

    

PRICE

    

(in years)

    

(in thousands)

Options outstanding

3,859,775

$

210.08

4.9

$

161,462

Options vested or expected to vest

3,594,434

206.74

4.6

160,728

Options exercisable

2,505,720

189.03

3.3

154,493

Schedule of stock-based compensation expense

THREE MONTHS ENDED

NINE MONTHS ENDED

NOVEMBER 1,

NOVEMBER 2,

NOVEMBER 1,

NOVEMBER 2,

    

2025

    

2024

    

2025

2024

(in thousands)

Stock-based compensation expense(1)

$

11,308

$

11,684

$

35,315

$

33,757

(1)On October 18, 2020, our Board of Directors granted Mr. Friedman an option to purchase 700,000 shares of our common stock with an exercise price equal to $385.30 per share under the Stock Incentive Plan. The option resulted in aggregate non-cash stock compensation expense of $174 million, of which $0.9 million and $3.7 million was recognized during the nine months ended November 1, 2025 and November 2, 2024, respectively. Compensation expense for this award was fully recognized as of the first quarter of fiscal 2025.
Schedule of total unrecognized compensation expense and weighted average remaining term

UNRECOGNIZED

WEIGHTED-

STOCK BASED

AVERAGE

COMPENSATION

REMAINING TERM

(in thousands)

(in years)

Unvested options

$

136,340

4.6

Unvested restricted stock and restricted stock units

7,759

1.9

Total

$

144,099